Insider Transactions in Q1 2021 at Checkmate Pharmaceuticals, Inc. (CMPI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
33,220
+2.11%
|
$365,420
$11.17 P/Share
|
|
Mar 26
2021
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,484
+0.46%
|
$41,808
$12.15 P/Share
|
|
Mar 25
2021
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
10,036
+1.33%
|
$120,432
$12.35 P/Share
|
|
Feb 26
2021
|
Kleem Chaudhary Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.0%
|
$4,000
$2.62 P/Share
|
|
Jan 27
2021
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
1,701
+0.23%
|
$22,113
$13.05 P/Share
|
|
Jan 19
2021
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.07%
|
$6,500
$13.09 P/Share
|
|
Jan 14
2021
|
Kleem Chaudhary Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+25.0%
|
$4,000
$2.62 P/Share
|